Journal of Pharmaceutical Investigation

The Korean Society of Pharmaceutical Sciences and Technology (한국약제학회)
권호 표지
DOI QR코드

DOI QR Code

Development of Poly(D,L-lactic acid) Microspheres Containing Lorazepam

로라제팜을 함유한 poly(D,L-lactic acid) 마이크로스피어 개발

  • Published : 2006.06.21
Download PDF
⟨ Previous Next ⟩

Abstract

Poly(D,L-lacic acid)(PLA) microshperes containing loazepam were prepared by a solvent-emulsion evaporation method and their release patterns were investigated in vitro. Various batches of microspheres with different size and drug content were obtained by changing the ratio of lorazepam to PLA, PLA concentration in the dispersed phase and stirring rate. Rod-like lorazepam crystals on microsphere surface, which were released rapidly and could act as a loading dose, were observed with increasing drug content. The release rate was increased with increase in drug contents and decrease in the molecular weight of PLA. The release rate of lorazepam for long-acting injectable delivery system in vitro, which would aid in Predicting in vivo release Profile, could be controlled by properly optimizing various factors affecting characteristics of microspheres.

Keywords

References

  1. Y.W. Chien (Ed.), Novel Drug Delivery Systems, Marcel Dekker, New York, U.S.A,1992
  2. J.R. Robinson (Ed.), Sustained and Controlled Release Drug Delivery Systems, Marcel Dekker, New York, U.S.A., 1978
  3. P. Johnson and J.G. Lloyed-Jones (Eds.), Drug Delivery Systems: Fundamentals and Techniques, Ellis Horwood, England Chichester, 1987
  4. B. Conti, F. Pavanetto and I. Genta, Use of polylactic acid for the preperation of microparticulate drug delivery system, J. Microencapsulation, 9, 153-166 (1992) https://doi.org/10.3109/02652049109021231
  5. R.J. Linhardt, Biodegradable polymers for controlled release of drugs: In Controlled Release of Drugs: Polymers and Aggregate Systems, M. Rosoff (Ed.), VCH Publishers, New York, U.S.A, pp. 53-96, (1988)
  6. M. Chasin and R. Langer (Eds.), Biodegradable Polymers as Drug Delivery Systems, Marcel Dekker, New York, U.S.A., 1990
  7. T. Kawaguchi, A Tsugane, K. Higashide, H. Endoh, H. Kanno, T. Seki, K. Juni, S. Fukushima and M. Nakino, Control of drug release with a combination of prodrug and polymer matrix, J. Pharm. Sci., 81, 508-512 (1992) https://doi.org/10.1002/jps.2600810606
  8. C.G Pitt, M.M. Gratzl, A.R. Jeffcoat, R. Zweidinger and A. Schindler, Sustained drug delivery systems, J. Pharm. Sci. 68, 1534-1538 (1979) https://doi.org/10.1002/jps.2600681219
  9. A. Schindler, R. Jeffcoat, G.L. Kimmel, C.G. Pitt, M.E. Wall and R. Zweidinger (Eds.), Contemporary Topics in Polymer Science, Plenum Press, New York, U.S.A, pp. 251-286 (1977)
  10. D.L. Wise, T.D. Fellmann, J.E. Sanderson and R.L. Wentworth (Eds.), Lactic-Glycolic Acid Polymers in Drug Carriers in Biology and Medicine, Academic Press, Orlando, Fla., pp. 237-270 (1979)
  11. L.R. Beck, D.R. Cowsar, D.H. Lewis, R.J. Cosgrove, C.T. Riddle, S.L. Lowry and T. Epperly, A new long-acting injectable microcapsule system for the administration of progesterone, Fertility and Sterility, 31, 545-551 (1979) https://doi.org/10.1016/S0015-0282(16)44002-1
  12. L.R. Beck, C.E. Flowers, V.Z. Pope, W.H. Wilborn and T.R. Tice, Clinical evaluation of improved injectable microcapule contraceptive system, Am. J. Obstet. Gynecol., 147, 815-821 (1983) https://doi.org/10.1016/0002-9378(83)90046-7
  13. H. Endoh, T. Kawaguchi, T. Seki, T. Hasegawa and K. Juni, Controlled release of 5-Fluoro-2-deoxyuridine by the combination of prodrug and polymer matrix, Chem. Pharm. Bull., 39, 458-464 (1991) https://doi.org/10.1248/cpb.39.458
  14. K. Juni, J. Ogata, M. Nakano, T. Ichihara, K. Mori and M. Akagi, Preparation and evaluation in vitro of polylactic acid micropsheres containing doxorubicin, Chem. Pharm. Bull., 33, 313-318 (1985) https://doi.org/10.1248/cpb.33.313
  15. G. Spenlehauer, M. Veillard and J.P. Benoit, Formation and characterization of cisplatin loaded poly(d,1-lactide) microspheres for chemoembolization, J. Pharm. Sci., 75, 750-755 (1986) https://doi.org/10.1002/jps.2600750805
  16. J.H.P. Woodland and S. Yolles, Long-acting delivery systems for narcotic antagonists, J. Med. Chem., 16, 897-901 (1973) https://doi.org/10.1021/jm00266a007
  17. N. Wakiyama, K. Juni and M. Nakano, Preparation and evaluation in vitro of polylactic acid microspheres containing local anesthetics, Chem. Pharm. Bull., 29, 3363-3368 (1981) https://doi.org/10.1248/cpb.29.3363
  18. N. Wakiyama, K. Juni and M. Nakano, Preparation and evaluation in vitro of polylactic acid microspheres containing dibucaine, Chem. Pharm. Bull., 30, 3719-3727 (1982) https://doi.org/10.1248/cpb.30.3719
  19. A.K. Kwong, S. Chou, A.M. Sun, M.V. Sefton and M.F.A. Goosen, In vitro and in vivo release of insulin from polyl (actic acid) microbeads and pellets, J. Controlled Release, 4, 47-62 (1986) https://doi.org/10.1016/0168-3659(86)90033-7
  20. Y. Ogawa, H. Okada, M. Yamamoto and Y. Shimamoto, In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly(lactic!glycolic) acids in vitro degradation ofthese polymers, Chem. Pharm. Bull., 36, 2576-2581 (1988) https://doi.org/10.1248/cpb.36.2576
  21. Y. Ogawa, H. Okada, T. Heya and Y. Shimamoto, Controlled release of LHRH agonists, leuprolide acetate, from micro- capsules: Serum drug level profiles and pharmacological effects in animals, J. Pharm. Pharmacol., 41, 439-444 (1989) https://doi.org/10.1111/j.2042-7158.1989.tb06497.x
  22. I. Yamakawa, Y. Tsushima, R. Machida and S. Watanabe, In vitro and in vivo release of poly(DL-lactic acid) micro- spheres containing neurotensin analogue prepared by novel oil-in water solvent evaporation method, J. Pharm. Sci., 81, 808-811 (1992) https://doi.org/10.1002/jps.2600810817
  23. I. Yamakawa, Y. Tsushima, R. Machida and S. Watanabe, Preparation ofneurotensin analogue-containing poly(DL-lactic acid) microsperes formed by oil-in water solvent evaporation, J. Pharm. Sci., 81, 899-903 (1992) https://doi.org/10.1002/jps.2600810912
  24. B.J.A. Furr and F.G. Hutchinson, A biodegradable delivery system for peptides: Preclinical experience with the gona- dotrophin- releasing hormone agonist $Zoladex^{R}$', J. Controlled Release, 21, 117-128 (1992) https://doi.org/10.1016/0168-3659(92)90013-H
  25. F.G. Hutchinson and B.J.A. Furr, Biodegradable polymer systems for the sustained release of polypeptides, J. Controlled Release, 13, 279-294 (1990) https://doi.org/10.1016/0168-3659(90)90018-O
  26. K. Suzuki and J.C. Price, Microencapsulation and dissolution properties of a neuroleptic in a biodegradable polymer, poly (d,l-lactide), J. Pharm. Sci., 74, 21-24 (1985) https://doi.org/10.1002/jps.2600740106
  27. J. Dreyfus, J.J. Ross and B.C. Schreiber, Excretion and biotransformation of the enanthate ester of $fluphenazine-^{14}C$ by the dog, J. Pharm. Sci., 60, 829-833 (1971) https://doi.org/10.1002/jps.2600600606
  28. S.M. Li, H. Garreau and M. Vert, Structure-property relationships in the case of the degradation of massive aliphatic poly-($\alpha$-hydroxy acids) ill aqueous media, part 1: poly(DL-lactic acid), J. Materi. Sci.; Materials in medicine, 1, 123-130 (1990) https://doi.org/10.1007/BF00700871
  29. K. Makino, M. Arakawa and T. Kondo, Preparation and in vitro degradation properties of polylactide microcapsules, Chem. Pharm. Bull., 33, 1195-1201 (1985) https://doi.org/10.1248/cpb.33.1195
  30. I.J. Oh, J.Y. Oh and K.C. Lee, Assessment of biodegrada- bility of polymeric microspheres in vivo: poly(DL-lactic acid), poly(L-lactic acid) and poly(DL-lactide-co-glycolide) microspheres, Arch. Pharm. Res., 16, 312-317 (1993) https://doi.org/10.1007/BF02977522
  31. J. Claassen, L.J. Hirsch and S.A. Mayer, Treatment of status epilepticus: A survey ofneurologists, J. Neurological Sci., 211, 37-41 (2003) https://doi.org/10.1016/S0022-510X(03)00036-4
  32. J.-Y. Chung, J.-Y. Cho, K.-S. Yu, J.-R. Kim, H.-R. Jung, K-S. Lim, I.-J. Jang and S.-G Shin, Effect of the UGT2B15 genotype on the pharmacokinetics, pharmacodynamics, and drug interactions of intravenous lorazepam in healthy volunteers, Clinical Pharmacology & Therapeutics, 77, 486-494 (2005) https://doi.org/10.1016/j.clpt.2005.02.006
  33. G.L. Klerman, Overview of the cross-national collaborative panic study, Arch. Gen. Psychiatry, 45, 407-412 (1988) https://doi.org/10.1001/archpsyc.1988.01800290021003
  34. Y.W. Chien (Ed.), Novel Drug Delivery Systems, Marcel Dekker, New York, U.S.A., pp. 465-545 (1982)
  35. S.N. Muchohi, K Obiero, G.O. Kokwaro, B.R. Ogutu, I.M. Githiga, G. Edwards and C.R.J.C. Newton, Determination of lorazepam in plasma from children by high-performance liquid chromatography with UV detection, Journal of Chromatography B, 824, 333-340 (2005) https://doi.org/10.1016/j.jchromb.2005.07.040
  36. X.-P. Lee, T. Kumazawa, J. Sato, Y. Shoji, C. Hasegawa, C. Karibe, T. Arinobu, H. Seno and K Sato, Simple method for the determination ofbenzodiazepines in human body fluids by high-performance liquid chromatography-mass spectrometry, Analytica Chimica Acta, 492, 223-231 (2003) https://doi.org/10.1016/S0003-2670(03)00304-0
  37. H. Zhu and J. Luo, A fast and sensitive liquid chromatographic- tandem mass spectrometric method for assay of lorazepam and application to pharmacokinetic analysis, J. Pharmaceutical and Biomedical Analysis, 39, 268-274 (2005) https://doi.org/10.1016/j.jpba.2005.02.024
  38. D.L. Thies and P.B. Bowman, Development of liquid chromatographic method for the determination of triazolo-benzodiazepines, J. Chromato., 268, 92-98 (1983) https://doi.org/10.1016/S0021-9673(01)95391-9
  39. J. Heller, Biodegradable polymers in controlled drug delivery, CRC Crit. Rev. Ther. Drug. Carrier Systems, 1, 39-90 (1984)
  40. C. Sturesson, J. Carlfors, K Edsman and M. Andersson, Preparation of biodegradable poly(lactic-co-glycolic)acid microspheres and their in vitro release of timolol maleate, Int. J. Pharm., 89, 235-244 (1993) https://doi.org/10.1016/0378-5173(93)90249-F